Due to the well-known function of ANGPTL8 in lipid regulation, it is assumed that its persistent increase results in dyslipidaemia and increased insulin resistance, which aggravates metabolic stress and ultimately leads to the development of metabolic diseases like T2D and complications such as DN. The gene discussed is ANGPTL8; the disease is metabolic disease.